AROMATASE INHIBITORS IN THE TREATMENT OF ADVANCED BREAST-CANCER

被引：67

作者：

MILLER, WR

机构：

来源：

CANCER TREATMENT REVIEWS | 1989年 / 16卷 / 02期

关键词：

D O I：

10.1016/0305-7372(89)90012-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：83 / 93

页数：11

共 72 条

[1]

ADAMS J, 1981, CANCER RES, V41, P4720

[2] INHIBITION OF PERIPHERAL AROMATIZATION OF ANDROSTENEDIONE TO ESTRONE IN POST-MENOPAUSAL WOMEN WITH BREAST-CANCER USING DELTA-1 TESTOLOLACTONE [J].

BARONE, RM ;

SHAMONKI, IM ;

SIITERI, PK ;

JUDD, HL .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (05) :672-676

[3]

BHATNAGAR AS, 1987, AROMATASEHEMMER NEUE, P23

[4] INACTIVATION OF AROMATASE INVITRO BY 4-HYDROXY-4-ANDROSTENE-3, 17-DIONE AND 4-ACETOXY-4-ANDROSTENE-3, 17-DIONE AND SUSTAINED EFFECTS INVIVO [J].

BRODIE, AMH ;

GARRETT, WM ;

HENDRICKSON, JR ;

TSAIMORRIS, CH ;

MARCOTTE, PA ;

ROBINSON, CH .

STEROIDS, 1981, 38 (06) :693-702

[5] EFFECT OF AN AROMATASE INHIBITOR, 4-HYDROXY-4-ANDROSTENE-3,17-DIONE, ON ESTROGEN-DEPENDENT PROCESSES IN REPRODUCTION AND BREAST-CANCER [J].

BRODIE, AMH ;

SCHWARZEL, WC ;

SHAIKH, AA ;

BRODIE, HJ .

ENDOCRINOLOGY, 1977, 100 (06) :1684-1695

[6]

BRODIE AMH, 1982, ADV EXP MED BIOL, V138, P179

[7]

BRODIE AMH, 1980, ENDOCRINOLOGY, V110, P119

[8] 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER [J].

COOMBES, RC ;

GOSS, P ;

DOWSETT, M ;

GAZET, JC ;

BRODIE, A .

LANCET, 1984, 2 (8414) :1237-1239

[9]

COOMBES RC, 1989, P ROYAL SOC EDINBURG

[10]

DOWSETT M, 1984, J CLIN ENDOCR METAB, V58, P99, DOI 10.1210/jcem-58-1-99

← 1 2 3 4 5 6 7 8 →